Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
The incorporation of 4-n-butyl resorcinol into liposomes was resulted in enhanced drug stability, improved skin permeation, as well as increased tyrosinase inhibitory potential which in turns resulted in more efficient melanogenesis inhibition (Huh et al., 2010)
PMID: 34734994
Twelve+ Phase 3 trials, three FDA approvals, a published CVOT in 13,165 patients, and a mature prescribing-information safety envelope
Insomnia can be linked to stress, pain, shift work, caffeine, untreated sleep apnea, restless legs, depression, anxiety, medication effects, or withdrawal
University of York: Centre for Reviews and Dissemination
US$ 27.71
US$ 29.67
US$ 22.83
US$ 25.65
US$ 20.62
US$ 21.88
US$ 29.67
